The length of time it takes to see results from semaglutide can vary depending on individual factors such as the person's starting weight, diet, exercise habits, and other health conditions
In our previous report 20 and in this study, we demonstrated that, in semaglutide-treated patients, a greater degree of weight loss was associated with larger improvements in various KCCQ domains, suggesting that weight loss is an important factor in the health status benefits of semaglutide
Food and Drug Administration emphasizes following proper storage guidelines for injectable medications
Some countries, such as Australia and New Zealand, have adopted guidelines similar to these recommendations, asking patients to fast from solids for 24 hours
The absence of retinopathy and a short duration of diabetes are the strongest predictors that kidney disease is not diabetes-related, although DKD may still occur in some people without retinopathy